Systemic vascular phenotypes of Loeys-Dietz syndrome in a child carrying a de novo R381P mutation in TGFBR2: a case report
- Kiyoshi Uike†1,
- Yuki Matsushita†1,
- Yasunari Sakai1Email author,
- Osamu Togao2,
- Michinobu Nagao3,
- Yoshito Ishizaki1,
- Hazumu Nagata1,
- Kenichiro Yamamura1,
- Hiroyuki Torisu1 and
- Toshiro Hara1
© Uike et al.; licensee BioMed Central Ltd. 2013
Received: 16 August 2013
Accepted: 8 November 2013
Published: 12 November 2013
Loeys–Dietz syndrome, also known as Marfan syndrome type II, is a rare connective tissue disorder caused by dominant mutations in transforming growth factor-beta receptors (TGFBR1 and 2).
We report a 7-year-old Japanese boy with Loeys–Dietz syndrome who carried a novel, de novo missense mutation in TGFBR2 (c.1142g > c, R381P). He showed dysmorphic faces and skeletal malformations that were typical in previous cases with Loeys-Dietz syndrome. The cardiac studies disclosed the presence of markedly dilated aortic root and patent ductus aorteriosus. The cranial magnetic resonance imaging (MRI) and angiography (MRA) detected the tortuous appearances of the bilateral middle cerebral and carotid arteries.
This study depicts the systemic vascular phenotypes of a child with Loeys–Dietz syndrome that were caused by a novel heterozygous mutation of TGFR2. A large cohort with serial imaging studies for vascular phenotypes will be useful for delineating the genotype-phenotype correlations of Loeys–Dietz syndrome.
KeywordsLoeys–Dietz syndrome Transforming growth factor-beta receptor 2 (TGFBR2) Vascular phenotypes Magnetic resonance imaging (MRI)
Loeys–Dietz syndrome is a rare congenital disorder characterized by loose connective tissue [1, 2]. As a variant form of Marfan syndrome, affected individuals exhibit progressive vascular diseases such as dilation of the aortic root, aortic dissection and valvular insufficiency [1–3]. In addition to these common phenotypes, patients with Loeys–Dietz syndrome manifest distinct anomalies, such as ocular hypertelorism, high-arched palate, bifid uvula, scoliosis and clubfoot [1, 2].
Vascular complications in Loeys–Dietz syndrome are known to progress more rapidly than those in Marfan syndrome [2, 3]. Hence the precise diagnosis of Loeys–Dietz syndrome is a critical issue in the long-term management of affected individuals. In this report, we present a Japanese boy with Loeys–Dietz syndrome who carried a novel mutation in the TGFBR2 gene. This study highlights the moderate to severe vascular phenotypes that resulted from an R381P mutation in TGFBR2.
MR imaging was performed using a 3.0T system (Intera Achieva; Philips Medical Systems, Best, Netherlands). Polymerase chain reaction (PCR) amplifying the coding exons of TGFBR2 (chr3:30647994–30735633) was performed as previously described [1, 2, 4]. Sequencing reactions were performed with the BigDye® Terminator v3.1 cycle sequencing kit (Life Technologies, Grand Island, NY, U.S.A.) according to the manufacturer’s protocol.
This report presents the systemic phenotypes of Loeys–Dietz syndrome that were caused by a novel TGFBR2 mutation (R381P) in a Japanese case. The systemic vascular phenotypes of this case indicate the strong penetrance as well as the dominant effects of the heterozygous missense mutation.
The TGFBR2 gene encodes transforming growth factor-beta receptor II (70/80 kDa), a membrane-bound, serine/threonine kinase domain-containing protein. This protein forms a heterodimeric complex with another receptor protein, thereby activating the downstream signaling molecules, such as SMAD proteins, upon stimulation by TGF-beta ligands. Previous studies showed that the majority of pathogenic TGFBR2 mutations were identified in the exons encoding the protein kinase domain [1–3]. In vitro studies suggested that such mutations disturbed not only the kinase activity of TGFBR2, but also internalization process of the receptor, suggesting the dominant effects of heterozygous mutations. Given that the R381P mutation in this case (Figure 3A) was also located at the kinase domain of TGFBR2, we speculated that the mutation caused deleterious effects on both its kinase activity and the receptor internalization. An angiotensin II receptor antagonist, losartan, has been recently shown to down-regulate the expression of TGFBRs, and thus proved to be effective in preventing the progressive aortic dilation and development of aneurysm in Marfan and Loeys-Dietz syndromes. A large cohort, including the present case, is thus needed to monitor its efficacy and side effects, thereby elucidating prognostic factors and contraindications of the therapies.
It is well known that prevention of aortic dilation is a vital issue for the long-term survival of patients with Loeys-Dietz syndrome. On the other hand, there are no reports clearly demonstrating the association of Marfan or Loeys-Dietz syndrome with neurovascular complications [7, 8]. Nonetheless, recent reports showed sporadic cases with intracranial aneurysm as well as tortuosity of carotid arteries in this disorder [7, 9, 10]. Given the progressive nature of the cardiovascular phenotypes of Loeys–Dietz syndrome, one could argue that only severely affected cases may experience such late-onset neurovascular complications. It also remains to be determined whether the enlarged perivascular lumens in this case (Figure 5A-C) are associated with the neurovascular phenotypes of Loeys-Dietz syndrome. Future studies will address the issues of their genotype-phenotype correlations, particularly on their comorbidity with neurovascular complications. Large cohorts with serial imaging studies can be considered to determine whether certain genotypes may correlate to their specific phenotypes.
This study was conducted in compliance with the institutional review board at Kyushu University Hospital. Written informed consent was obtained from the patient’s parents for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
We thank Dr. Steve Maricich (Case Western University) for critical reading of this manuscript. This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKEN #23810025 to Y.S., 24791072 to K.Y., 23591503 to H.T., 23591502 to Y.I., and 22249043 to T.H.), Life Science Foundation of Japan (Y.S.) and the Takeda Science Foundation (Y.S.).
- Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, et al: A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005, 37: 275-281. 10.1038/ng1511.PubMedView ArticleGoogle Scholar
- Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, et al: Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006, 355: 788-798. 10.1056/NEJMoa055695.PubMedView ArticleGoogle Scholar
- Judge DP, Dietz HC: Marfan’s syndrome. Lancet. 2005, 366: 1965-1976. 10.1016/S0140-6736(05)67789-6.PubMedPubMed CentralView ArticleGoogle Scholar
- Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, et al: Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet. 2004, 36: 855-860. 10.1038/ng1392.PubMedPubMed CentralView ArticleGoogle Scholar
- Rodrigues VJ, Elsayed S, Loeys BL, Dietz HC, Yousem DM: Neuroradiologic manifestations of Loeys-Dietz syndrome type 1. Am J Neuroradiol. 2009, 30: 1614-1619. 10.3174/ajnr.A1651.PubMedView ArticleGoogle Scholar
- Togashi Y, Sakoda H, Nishimura A, Matsumoto N, Hiraoka H, Matsuzawa Y: A Japanese family of typical Loeys-Dietz syndrome with a TGFBR2 mutation. Intern Med. 2007, 46: 1995-2000. 10.2169/internalmedicine.46.0467.PubMedView ArticleGoogle Scholar
- Maski KP, Sengupta S, Silvera M, Rivkin MJ: Intracranial artery dissection in an adolescent with Marfan syndrome. Pediatr Neurol. 2011, 45: 39-41. 10.1016/j.pediatrneurol.2010.12.011.PubMedView ArticleGoogle Scholar
- van den Berg JS, Limburg M, Hennekam RC: Is Marfan syndrome associated with symptomatic intracranial aneurysms?. Stroke. 1996, 27: 10-12. 10.1161/01.STR.27.1.10.PubMedView ArticleGoogle Scholar
- Hughes BD, Powers CJ, Zomorodi AR: Clipping of a cerebral aneurysm in a patient with Loeys-Dietz syndrome: case report. Neurosurgery. 2011, 69: E746-E755. 10.1227/NEU.0b013e31821964a3.PubMedView ArticleGoogle Scholar
- Rahme RJ, Adel JG, Bendok BR, Bebawy JF, Gupta DK, Batjer HH: Association of intracranial aneurysm and Loeys-Dietz syndrome: case illustration, management, and literature review. Neurosurgery. 2011, 69: E488-E492. 10.1227/NEU.0b013e318218cf55.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.